SectorBiological Technology
Established Date--
Listing Date06/02/2007
ExchangeNASDAQ Stock Exchange
Full-time Employees915
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressFour Tower Bridge, 200 Barr Harbor Drive, Suite 200, West Conshohocken, Pennsylvania
Business
IntroductionMadrigal Pharmaceuticals, Inc., was established in March 2000 and began operations in July 2001. The company is a biopharmaceutical company focused on providing new treatments for metabolic dysfunction-related steatohepatitis. Steatohepatitis is a serious liver disease with highly unmet medical needs that can lead to cirrhosis, liver failure, cancer, liver transplant needs and premature death. The company's drug, Rezifra, is a once-daily oral liver-directed thyroid hormone receptor beta agonist designed to target a key underlying cause of MASH.
